Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.29 USD | -5.46% | -7.56% | -23.61% |
01:48pm | Earnings Flash (ALIM) ALIMERA SCIENCES Posts Q1 Revenue $23M, vs. Street Est of $22.3M | MT |
25/03 | Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.61% | 18Cr | |
-2.47% | 8.94TCr | |
+2.76% | 4.07TCr | |
-12.38% | 3.28TCr | |
+52.41% | 2.5TCr | |
-17.32% | 1.53TCr | |
-42.45% | 1.16TCr | |
-10.48% | 1.15TCr | |
+6.14% | 898.19Cr | |
-7.72% | 822.67Cr |
- Stock Market
- Equities
- ALIM Stock
- News Alimera Sciences, Inc.
- HC Wainwright Adjusts Price Target on Alimera Sciences to $9 From $8, Reiterates Buy Rating